Bridge to Life Ltd.

HOPE for the Week: 100 Hypothermic Oxygenated Perfusion liver transplants in a Portuguese centre This abstract from the Centro Hospitalar e Universitário de Coimbra presented at the ELITA Summit concluded that HOPE allowed for more extended criteria grafts utilization, and emphasized good graft function on the immediate postoperative period. Also, NAS rate decreased. #HOPEForTheWeek #LiverTransplantation #MachinePerfusion https://lnkd.in/gGAch9hS

The International team at #BridgetoLife recently convened for our bi-annual off-site meeting in Marlow. It was wonderful to bring the entire team together for training, team building, celebrating our achievements from the past year, and planning for the future. #TeamBuilding #FuturePlanning

🌟 Proud Sponsor of the TADS Foundation Gold Tournament 🌟 We were thrilled to join the TADS Foundation Gold Tournament this week, hosted by Transplantation and Donation Sciences MSBS, PSM Program. It was a privilege to support such a wonderful event alongside our colleagues Laura Cwynar and Dan Bergey from Essential Pharmaceuticals, LLC. At Bridge to Life, we believe in supporting initiatives that make a real difference in people's lives and, in this case, even our competition.😉 The tournament not only showcased incredible skill and sportsmanship but also raised crucial awareness and funds for a cause that impacts countless individuals. Thank you to Julie DeSantis and everyone involved in organizing this remarkable event. We are grateful for the opportunity to contribute to the development of emerging leaders in organ procurement and look forward to continuing our support for the TADS Foundation and its vital mission. #TADSFoundation #OrganDonation #TransplantationSciences #UniversityOfToledo #CommunitySupport

🌟 HOPE FOR THE WEEK: Excited to share findings from the latest study on HOPE-treated liver transplants! The international, multicentre cohort study examined long-term outcomes from 1202 transplantations across 22 European centers. Key highlights include excellent 5-year survival rates and low incidences of graft loss due to primary non-function or ischemic cholangiopathy, regardless of donor type or risk category. These results underscore HOPE's efficacy at IDEAL-D stage 4, reinforcing its role in enhancing liver transplant outcomes. #LiverTransplant

Thank you Mauricio Flores Carvalho for initiating this generous gift to Transplant House! A gift of this size has significant impact here. We are so pleased to be part of the transplant ecosystem with Bridge to Life Ltd.

🌟 HOPE FOR THE WEEK: Economic Benefit of Hypothermic Liver Perfusion Recent studies have demonstrated compelling benefits of hypothermic oxygenated perfusion (HOPE) for liver allografts, significantly enhancing outcomes post-transplant. Key findings include: - Reduced hospital length of stay (LOS) for patients receiving HOPE-treated livers. - Lower incidence of biliary complications compared to traditional methods. Moreover, a comprehensive financial assessment using interim outcomes from a US clinical trial underscores the economic advantages of HOPE. This analysis, based on 6-month follow-up data, reveals potential cost savings and improved resource allocation in liver transplant procedures. This innovative approach not only improves patient outcomes but also offers promising economic benefits, paving the way for more efficient and sustainable healthcare practices in transplant medicine. #LiverTransplant #HOPE #MedicalInnovation #HealthcareEconomics #TransplantMedicine

Riccardo De Carlis gave a fascinating presentation on the positive outcomes of prolonged hypothermic oxygenated machine perfusion in liver transplantation at the SISQT 2024 conference in L'Aquila last week. #SISQT2024 #LiverTransplant #Epatologia #OrganPreservation

🌟 HOPE FOR THE WEEK: Decreased Ischemic Cholangiopathy with Hypothermic Oxygenated Perfusion Dive into our latest sub-analysis on ischemic cholangiopathy (IC) from the Bridge to HOPE Trial! VitaSmart demonstrated a reduced number of cases of clinically significant IC and mitigated IC-related graft loss compared to standard cold storage. To learn more, view full presentation here: https://ow.ly/njQo50Sr0E5 #ATC2024Philly #HOPEForTheWeek

🌟 HOPE FOR THE WEEK: Explore the pioneering Bridge to HOPE Trial findings presented at ATC: https://ow.ly/HkCJ50Sr0nL Analysis from the trial demonstrated reductions in EAD and enhanced clinical outcomes with HOPE compared to standard cold storage. #ATC2024Philly #EAD #HOPEvsSCS #HOPEForTheWeek

Looking forward to Riccardo De Carlis (Milano) talk: È POSSIBILE PROLUNGARE LA PERFUSIONE EX VIVO DEL GRAFT EPATICO? at SISQT 2024 in L'Aquila. Take a look at the full program of events 👀https://lnkd.in/eNrAJfWG #SISQT2024 #LiverTransplant #Epatologia